Skip to content
GlycoZym
  • Home
  • Science & Technology
  • Investors
  • Patent info
  • Services
GlycoZym
  • Investors
  • License and Partnership
  • Patent info
  • Science & Technology
  • Services

Investors

GlycoZym USA Inc was founded in 2006 and is privately held with a single angel investor.

GlycoZym is actively seeking financing and partnerships for development of new biomarker assays and therapeutics for oncology, autoimmune, and inflammatory diseases.

Recent Posts

  • Glycan Modification and Its Effect on Monoclonal Antibody Therapeutics: Enhancing Effectiveness Through Glycan Engineering
  • The Rise of Glycobiology: Advancing Personalized Medicine Through Glycan Analysis and Profiling
  • Harnessing the capability of Glycan-Protein Associations: A cutting-edge technique in Vaccine Design
  • Exploiting the capability of Glycan-Protein Associations: A new approach in Vaccine Design
  • Glycan-Based Treatments: Exploring the Capabilities of Glycan Research in Contemporary Healthcare

Recent Comments

  1. A WordPress Commenter on Hello world!

Archives

  • June 2025
  • May 2025
  • April 2025
  • December 2022
  • December 2021
  • November 2021

Categories

  • Blog
  • Uncategorized

Copyright © 2025 GlycoZym | Powered by Astra WordPress Theme